ARTICLES BY ROB WRIGHT
-
Building A $1 Billion Gene Therapy Company — In 6 Years10/21/2019
Matt Patterson, chairman and CEO of Audentes Therapeutics, shares the experiences that prepared him for building the gene therapy company he cofounded into a publicly traded business valued at nearly $2 billion, in just seven years.
-
Liz Barrett — Novartis Oncology's NextGen Leader11/12/2018
Liz Barrett recently sat down with Life Science Leader to share some of the formative experiences that shaped her into the leader she has become, including one of the most recent challenges she is embracing at Novartis.
-
The Intriguing Origins Of A Gene Therapy Biopharma2/7/2018
An inside look into how this fledgling biopharma has raised over $150 million and enlisted two high-profile CEOs from one of the hottest VC firms around, all in less than two years.
-
Are You Ready For The Future Of Biopharma Manufacturing?12/7/2017
In last’s year’s manufacturing outlook we delved into biopharma’s manufacturing capacity crunch. While lack of manufacturing capacity remains a challenge for the industry, the future of biopharma manufacturing has never looked so bright, and there are a variety of reasons why.
-
Will Kite Pharma Soar Higher In The Engineered T-Cell Race?7/1/2016
During Kite Pharma’s (NASDAQ: KITE) company presentation at the February 2015 BIO CEO Investor’s Conference in New York, Arie Belldegrun, M.D., created a noticeable buzz among attendees when touting the latest developments coming out of the company he founded back in 2009.